Vitaspring Biomedical annual net debt
2022
2023
2024
2025
2026
Vitaspring Biomedical Net Debt Growth & History (VSBC)
Vitaspring Biomedical's net debt was −$2,084 for fiscal 2026.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | −$2,084 | −$2,084 | — |
| 2025 | 2025-01-31 | $0 | −$93,334 | — |
| 2024 | 2024-01-31 | $93,334 | −$132,692 | −58.71% |
| 2023 | 2023-01-31 | $226,026 | −$146,257 | −39.29% |
| 2022 | 2022-01-31 | $372,283 | — | — |
Vitaspring Biomedical quarterly net debt
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | −$8,167 | −$8,167 | — |
| Q4 2026 | 2026-01-31 | −$2,084 | −$2,084 | — |
| Q3 2026 | 2025-10-31 | $0 | — | — |
| Q2 2026 | 2025-07-31 | $0 | — | — |
| Q1 2026 | 2025-04-30 | $0 | — | — |
| Q4 2025 | 2025-01-31 | $0 | — | — |
| Q4 2023 | 2023-01-31 | $226,026 | −$146,257 | −39.29% |
| Q3 2023 | 2022-10-31 | $21,854 | −$271,642 | −92.55% |
| Q2 2023 | 2022-07-31 | $78,181 | — | — |
| Q1 2023 | 2022-04-30 | $56,674 | — | — |
| Q4 2022 | 2022-01-31 | $372,283 | — | — |
| Q3 2022 | 2021-10-31 | $293,496 | — | — |
Vitaspring Biomedical net debt trends
Between the periods ended 2022-01-31 and 2026-01-31, Vitaspring Biomedical's net debt decreased from $372,283 to −$2,084, a change of −$374,367. The latest reported quarter, Q1 2027, shows −$8,167.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical source filings ↗